Richard Kennedy

8PUBLICATIONS
61CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 31, 2024
Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation.

Daryl Griffin, Robbie Carson, Debbie Moss

|Aug 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).

Holly Tovey, Orsolya Sipos, Joel S Parker

|Nov 03, 2021
Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer.

Eileen E Parkes, Kienan I Savage, Tong Lioe

|Jun 26, 2021
The clinical and molecular significance associated with STING signaling in breast cancer.

Eileen E Parkes, Matthew P Humphries, Elaine Gilmore

|Jul 27, 2019
A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer.

Richard D A Wilkinson, Roberta E Burden, Sara H McDowell

Pageof 2